Возраст домена | 21 год |
Дата окончания | Истек срок регистрации |
PR | 6 |
ИКС | |
Страниц в Google | 518 |
Страниц в Яндексе | 0 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 3558206 |
Alexa Country | 1070549 |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Commercial Partnerships | Cancer Research UK
n/a
n/a
UTF-8
119.87 КБ
2 500
26 402 симв.
22 670 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
cancerresearchuk.org | 7 | 8 |
0 | 20915 | 1294 | |
wikipedia.org | 5 | 9 |
0 | 5 | 6 | |
cam.ac.uk | 3 | 9 |
0 | 3566 | 253 | |
twitter.com | 2 | 10 |
0 | 11 | 8 | |
vandyke.com | 2 | 6 |
120 | 69852 | 13541 | |
indeed.co.uk | 1 | 6 |
0 | 3139 | 82 | |
guardian.co.uk | 1 | 7 |
0 | 60421 | 12754 | |
graduate-jobs.com | 1 | 5 |
0 | 79299 | 2885 | |
findaphd.com | 1 | 7 |
0 | 17143 | 7814 | |
ed.ac.uk | 1 | 9 |
600 | 3770 | 186 | |
dkfz.de | 1 | 6 |
30 | 172541 | 12073 | |
cancer.org | 1 | 8 |
0 | 7938 | 2700 | |
cancerresearch.org | 1 | 6 |
20 | 376627 | 110661 | |
breast-cancer-research.com | 1 | 7 |
40 | 20336050 | Нет данных | |
aicr.org | 1 | 6 |
30 | 268910 | 75003 | |
aacr.org | 1 | 8 |
0 | 157672 | 33650 | |
aacrjournals.org | 1 | 7 |
0 | 22356 | 8487 | |
Еще 33 сайта после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
Google Analytics | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 31 Августа 2012 ) | |
Количество ссылок на сайт | 12 |
Количество доменов, которые ссылаются на сайт | 11 |
Количество найденных анкоров | 8 |
Исходящие (внешние) ссылки домена | 1 |
Количество доменов, на которые ссылается сайт | 1 |
Количество исходящих анкоров | 1 |
Внешние ссылки главной страницы ( 9 ) | |
commercial.cancerresearchuk.org/our-company | Read more |
crtdiscoverylabs.com | Visit the CRUK-TDL website |
commercial.cancerresearchuk.org/licensing-opportunites | View our opportunities |
commercial.cancerresearchuk.org/have-idea | Get in touch |
twitter.com/CRT_News | Join us on Twitter |
twitter.com/CRUKResearch | |
linkedin.com/showcase/cancer-research-uk-translation-&-comme... | |
cancerresearchuk.org/privacy-statement | Privacy Statement |
cancerresearchuk.org | www.cruk.org |
Внутренние ссылки главной страницы ( 195 ) | |
# | Back to top |
/overview | Overview |
/our-people | Our People |
/our-network | <img> |
/history | History |
/services | Overview |
/project-development | Project Development |
/have-idea | Have an idea? |
/commercialisation | Commercialisation |
/drug-discovery | Drug Discovery |
/cruk-drug-discovery | CRUK Drug Discovery |
/clinical-development | Clinical Development |
/clinical-development-partnerships | CDP |
/imaging | Imaging |
/funding | Funding |
/our-projects | Overview |
/our-pipeline | Our Pipeline |
/licensing-opportunities | Licensing Opportunities |
/lo-small-molecules-search | Small Molecules |
/lo-biological-therapeutics-search | Biological Therapeutics |
/lo-enabling-technology-search | Enabling Technology |
/lo-biomarkers-search | Biomarkers |
/our-start-ups | Our Start-ups |
/research-tools | Research Tools |
news-and-events | Read more news |
/alliance-translational-research-centres-established-acceler... | Alliance of translational research centres established to accelerate global drug development |
/astex-pharmaceuticals-earns-54-m-milestone-phi-trial-initia... | Astex Pharmaceuticals Earns $5.4 M Milestone on PhI Trial Initiation of a FGFR Kinase Inhibitor |
/crt-adc-therapeutics-join-forces-antibody-drug-conjugates | CRT & ADC Therapeutics join forces on Antibody Drug Conjugates |
/crt-and-teva-pharmaceuticals-form-rd-alliance-cancer-dna-da... | CRT and Teva Pharmaceuticals Form R&D Alliance for Cancer DNA Damage Response Drugs |
/crt-institute-cancer-research-and-merck-serono-sign-wnt-lic... | CRT, The Institute of Cancer Research and Merck Serono sign WNT licensing deal |
/cruk-cambridge-institute-symposium | CRUK Cambridge Institute Symposium |
/cancer-research-uk-and-crt-collaborate-abcodia-discover-and... | Cancer Research UK and CRT collaborate with Abcodia to discover and develop tests for cancer |
/forma-therapeutics-and-crt-discover-cancer-drugs-targeting-... | FORMA Therapeutics and CRT to discover cancer drugs targeting deubiquitinating enzymes (DUBs) |
/new-board-appointment-crt | New board appointment for CRT |
/new-offices-crt | New offices for CRT |
/cruk-research-strategy-great-place-come-and-do-business | "This is a great place to come and do business" |
/2014-bio-international-convention | 2014 BIO International Convention |
/2014-medicinal-chemistry-gordon-research-conference | 2014 Medicinal Chemistry Gordon Research Conference |
/2014-year-review-infographic | 2014 Year in Review Infographic |
/2015-bio-international-convention | 2015 BIO International Convention |
/2016-bio-international-convention | 2016 BIO International Convention |
/26th-eortc-nci-aacr-symposium | 26th EORTC-NCI-AACR SYMPOSIUM |
/28th-eortc-nci-aacr-symposium | 28th EORTC-NCI-AACR Symposium |
/aacr-annual-meeting-2014 | AACR Annual Meeting |
/aacr-annual-meeting-2015 | AACR Annual Meeting 2015 |
/AACR2016 | AACR Annual Meeting 2016 |
/aacr-annual-meeting-2017 | AACR Annual Meeting 2017 |
/aacr-nci-eortc | AACR-NCI-EORTC 2015 |
/autm-2015-annual-meeting | AUTM 2015 Annual Meeting |
/AUTM2016 | AUTM 2016 Annual Meeting |
/academic-drug-discovery-workshop | Academic Drug Discovery Workshop |
/StructuralBiology2016 | Accelerator Structural Biology Conference 2016 |
/achilles-therapeutics-launched-funds-%C2%A3132-million-deve... | Achilles Therapeutics launched with funds of £13.2 million to develop immunotherapies for cancer |
/achilles-therapeutics-raises-%C2%A3100-million-oversubscrib... | Achilles Therapeutics raises £100 million in oversubscribed Series B financing |
/adaptate-biotherapeutics-formed-develop-antibody-based-ther... | Adaptate Biotherapeutics formed to develop antibody-based therapies that modulate gamma delta T-cells |
/alchemia-announces-licensing-fak-inhibitors-crt | Alchemia announces in-licensing of FAK inhibitors from CRT |
/aptamer-therapeutics-and-cancer-research-uk-announce-partne... | Aptamer Therapeutics and Cancer Research UK announce partnership for drug development programme |
/arxx-therapeutics-and-cancer-research-uk-announce-licence-a... | Arxx Therapeutics and Cancer Research UK announce license agreement |
/autolus-therapeutics-raised-1008-million | Autolus Therapeutics raised $100.8 million |
/azeria-therapeutics-announces-%C2%A3320-million-series-b-fi... | Azeria Therapeutics Announces £32.0 million Series B Financing |
/bacit-seeks-shareholder-approval-commit-%C2%A320m-and-join-... | BACIT seeks shareholder approval to commit £20m and join CRT Pioneer Fund as a limited partner |
/balversa%E2%84%A2-gains-us-marketing-approval-following-ear... | BALVERSA(TM) gains US marketing approval following early discovery work funded by CRUK |
/bicycle-therapeutics-and-cancer-research-uk-named-best-part... | BICYCLE THERAPEUTICS AND CANCER RESEARCH UK NAMED BEST PARTNERSHIP ALLIANCE OF THE YEAR AT 2017 SCRIP AWARDS |
/BioSpring2016 | BIO-EUROPE SPRING 2016 |
/bio-europe-spring-2014 | BIO-Europe Spring 2014 |
/bio-europe-autumn-2015 | Bio-Europe 2015 |
/bio-europe-autumn-2016 | Bio-Europe Autumn 2016 |
/bio-europe-spring-2017 | Bio-Europe Spring 2017 |
/bio-homecoming-2016 | Bio-Homecoming 2016 |
/bioinvents-bi-1206-antibody-enter-collaborative-trial | BioInvents BI-1206 antibody to enter collaborative Phase I/II trial |
/biowednesday-future-directions-oncology | BioWednesday: Future Directions in Oncology |
/biotech-and-money-london-2015 | Biotech and Money London 2015 |
/biotechs-and-city | Biotechs and the City |
/crt-highlighted-dowling-review-business-university-research... | CRT Highlighted in the Dowling Review of Business-University Research Collaborations |
/crt-pioneer-fund-banks-%C2%A320m-investment-bacit-and-expan... | CRT Pioneer Fund banks £20m investment from BACIT and expands agreement with Chroma Therapeutics |
/crt-pioneer-fund-collaborates-chroma-therapeutics-develop-c... | CRT Pioneer Fund collaborates with Chroma Therapeutics |
/crt-pioneer-fund-bacit-and-sareum-enter-agreement-fund-deve... | CRT Pioneer Fund, BACIT and Sareum enter agreement |
/crt-pioneer-fund-cancer-research-uk-and-nci-collaborate-boo... | CRT Pioneer Fund, Cancer Research UK and NCI collaborate to boost research against the ‘undruggable’ RAS |
/crt-and-alta-innovations-join-forces-commercialise-world-le... | CRT and Alta Innovations join forces to commercialise world-leading research |
/crt-and-astrazeneca-expand-successful-multi-project-cancer-... | CRT and AstraZeneca expand successful multi-project cancer metabolism alliance |
/crt-and-bioinvent-expand-collaboration-university-southampt... | CRT and BioInvent expand collaboration with University of Southampton scientists |
/crt-and-sv-life-sciences-form-artios-pharma-focus-dna-damag... | CRT and SV life sciences form Artios Pharma to focus on DNA damage response |
/crt-and-tevas-collaboration-yields-successful-outcome | CRT and Teva’s collaboration yields successful outcome with novel aPKC protein inhibitor cancer drug discovery candidate |
/crt-and-icr-enter-collaboration-janssen-discover-multiple-m... | CRT and The ICR enter collaboration with Janssen to discover multiple myeloma drug |
/crt-and-university-copenhagen-announce-agreement-adc-therap... | CRT and University of Copenhagen announce agreement with ADC Therapeutics to develop antibody treatments for cancer |
/crt-and-university-manchester-receive-success-payment-glaxo... | CRT and University of Manchester receive success payment from GlaxoSmithKline for cancer epigenetics research collaboration |
/crt-announces-license-agreement-msd-develop-inhibitors-prmt... | CRT announces license agreement with MSD to develop inhibitors of PRMT5 for cancer and blood disorders |
/crt-drives-novel-and-collaborative-drug-discovery-areas-%C3... | CRT drives novel and collaborative drug discovery in areas of "hot" cancer science |
/crt-signs-agreement-cimass-development-monoclonal-antibody-... | CRT signs agreement with CiMass for the development of a monoclonal antibody in the treatment of cancer. |
/crt-unveils-screen-test-potential-drugs-treat-oestrogen-pos... | CRT unveils screen test for potential drugs to treat oestrogen positive breast cancer |
/crt-university-manchester-and-glaxosmithkline-work-together... | CRT, University of Manchester and GlaxoSmithKline work together to generate new cancer drugs |
/crt%E2%80%99s-discovery-laboratories-extends-alliance-merck... | CRT’s Discovery Laboratories extends alliance with Merck to develop new cancer drugs |
/cancer-research-uk-forms-collaboration-sv-health-investors-... | CRUK forms partnership with SV Health Investors in life sciences investment fund to accelerate development of cancer medicines |
/cancer-research-uk-cancer-research-technology-and-asterias-... | CRUK, CRT and Asterias Biotherapeutics partner to trial immunotherapy vaccine for lung cancer |
/call-small-molecules-tool-compounds | Call for Small Molecules as Tool Compounds |
/cancer-advance-harvard-med | Cancer Advance Harvard Med |
/cancer-drug-discovery-and-preclinical-development-summit | Cancer Drug Discovery and Preclinical Development Summit |
/cancer-research-technology-pioneer-fund-announces-investmen... | Cancer Research Technology Pioneer Fund announces investment in blood cancer drugs |
/cancer-research-technology-and-forma-therapeutics-excellent... | Cancer Research Technology and FORMA Therapeutics: An excellent marriage |
/cancer-research-technology-and-medivir-collaborate-develop-... | Cancer Research Technology and Medivir collaborate to develop new class of cancer drugs |
/cancer-research-technology-and-nuevolution-sign-multi-targe... | Cancer Research Technology and Nuevolution sign multi-target deal to seek potential cancer drugs |
/cancer-research-technology-and-pangaea-biotech-sign-license... | Cancer Research Technology and Pangaea Biotech sign license agreement for new cancer drugs |
/cancer-research-technology-appoints-deborah-harland-non-exe... | Cancer Research Technology appoints Deborah Harland as Non-Executive Director |
/cancer-research-technology-introduces-ximbio-online-reagent... | Cancer Research Technology introduces Ximbio, an online reagents portal |
/cancer-research-technology-ucl-and-tusk-therapeutics-join-f... | Cancer Research Technology, UCL, and Tusk Therapeutics join forces to develop cancer immunotherapies |
/cancer-research-uk-and-bicycle-therapeutics-have-collaborat... | Cancer Research UK AND Bicycle Therapeutics have collaborated to trial new therapy for advanced solid tumours |
/cancer-research-uk-beatson-institute-starts-strategic-colla... | Cancer Research UK Beatson Institute starts strategic collaboration to accelerate KRAS drug discovery |
/cancer-research-uk-and-astrazeneca-launch-world-class-funct... | Cancer Research UK and AstraZeneca launch world class Functional Genomics Centre |
/cancer-research-uk-and-astrazeneca-sign-deal-repurpose-asth... | Cancer Research UK and AstraZeneca sign deal to repurpose asthma drug that could fight kidney cancer |
/cancer-research-uk-and-cancer-research-technology-announce-... | Cancer Research UK and Cancer Research Technology announce partnership with Monopar Therapeutics |
/cancer-research-uk-and-cancer-research-technology-join-forc... | Cancer Research UK and Cancer Research Technology join forces with Astellas on autophagy to find new cancer treatments |
/cancer-research-uk-and-cancer-research-technology-partner-t... | Cancer Research UK and Cancer Research Technology partner with TYG Oncology to develop next generation cancer vaccine |
/cancer-research-uk-and-hummingbird-bioscience-join-forces-a... | Cancer Research UK and Hummingbird Bioscience join forces to advance novel antibody drug into clinical trials |
/cancer-research-uk-and-leukaemia-lymphoma-research-team-boo... | Cancer Research UK and Leukaemia & Lymphoma Research team up to boost blood cancer trials |
/cancer-research-uk-and-medimmune-establish-joint-cruk-medi-... | Cancer Research UK and MedImmune establish joint CRUK-MEDI Alliance Laboratory to develop new biologic cancer medicines |
/cancer-research-uk-and-medimmune-launch-ground-breaking-bio... | Cancer Research UK and MedImmune launch ground-breaking biotherapeutics research centre in Cambridge |
/cancer-research-uk-and-newcastle-university-extend-successf... | Cancer Research UK and Newcastle University extend successful multi-project drug discovery alliance with Astex Pharmaceuticals |
/cancer-research-uk-and-institute-cancer-research-london-joi... | Cancer Research UK and the Institute of Cancer Research, London, join forces with Merck in new drug discovery alliance |
/cancer-research-uk-announces-drug-discovery-collaboration-c... | Cancer Research UK announces drug discovery collaboration with Celgene Corporation |
/cancer-research-uk-boost-entrepreneurs-science | Cancer Research UK boost entrepreneurs in science |
/cancer-research-uk-brings-commercialisation-arm-house | Cancer Research UK brings commercialisation arm in-house |
/cancer-research-uk-drug-launched-its-first-clinical-trial | Cancer Research UK drug launched in its first clinical trial |
/cancer-research-uk-collaborate-astrazeneca-screening-new-ca... | Cancer Research UK to collaborate with AstraZeneca in screening for new cancer medicines |
/cancer-research-uk-crt-and-amgen-trial-leukaemia-immunother... | Cancer Research UK, CRT and Amgen to trial leukaemia immunotherapy drug in other cancers |
/cancer-research-uk-lifearc-and-ono-pharmas-immunotherapy-al... | Cancer Research UK, LifeArc and Ono Pharma's Immunotherapy Alliance wins Best Partnership Alliance at 2019 Scrip Awards |
/cancer-research-uk-lifearc-and-ono-pharma-form-cancer-immun... | Cancer Research UK, LifeArc and Ono Pharma form cancer immunotherapy alliance |
/cancer-research-uk-ono-pharmaceutical-and-lifearc-are-short... | Cancer Research UK, ONO Pharmaceutical and LifeArc are shortlisted for a Scrip Award |
/cancer-research-uk%E2%80%99s-interview-network-life-science... | Cancer Research UK’s interview with The Network for Life Science Executive Leaders |
/cancer-research-uk%E2%80%99s-license-and-collaboration-part... | Cancer Research UK’s license and collaboration partner Tusk Therapeutics, is acquired by Roche |
/consortium-signs-deal-basilea-develop-resistance-busting-ca... | Consortium signs deal with Basilea to develop resistance-busting cancer drugs |
/elrig-drug-discovery-2015 | ELRIG Drug Discovery 2015 |
/faseb-lipids-and-lipid-regulated-kinases-cancer | FASEB: Lipids and Lipid Regulated Kinases in Cancer |
/first-human-trial-new-lung-cancer-immunotherapy | First-in-human trial for new lung cancer immunotherapy |
/forma-therapeutics-and-crt-form-third-virtual-company-advan... | FORMA Therapeutics and CRT form a third virtual company to advance deubiquitination assets |
/forma-therapeutics-and-crt-form-two-virtual-companies-advan... | FORMA Therapeutics and CRT form two virtual companies to advance deubiquitination assets |
/gammadelta-therapeutics-raises-seed-funding-abingworth | GammaDelta Therapeutics Raises Seed Funding from Abingworth |
/glythera-licenses-novel-payload-class-cancer-research-uk-de... | Glythera licenses novel payload class from Cancer Research UK for the development of next-generation antibody drug conjugates |
/highlights-ncri-conference-2013 | Highlights from the NCRI Conference 2013 |
/hitgen-announces-collaboration-drug-discovery-university-ma... | HitGen Announces Collaboration in Drug Discovery |
/hitgen-and-cancer-research-uk%E2%80%99s-manchester-institut... | Hitgen and Cancer Research UK’s Manchester Institute enter licence agreement in lung cancer |
/how-we-are-advancing-discoveries-beat-cancer | How we are advancing discoveries to beat cancer |
/inivata-completes-%C2%A3315-million-45m-series-fundraising-... | Inivata Completes £31.5 Million ($45M) Series A Fundraising Round |
/inivata-raises-%C2%A34m-realise-potential-ctdna-analysis-im... | Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests |
/inivata-completes-%C2%A3398-million-526m-series-b-round | Inivata completes £39.8 million ($52.6M) series B round |
/instinctif-partners-hosts-cancer-research-technology-event-... | Instinctif Partners hosts Cancer Research Technology event on innovative cancer diagnostics and treatments |
/international-deal-screen-potential-cancer-drugs-using-dna-... | International deal to screen potential cancer drugs using DNA 'barcodes' |
/major-drug-discovery-feasibility-study-merck-serono | MAJOR DRUG DISCOVERY FEASIBILITY STUDY WITH MERCK SERONO |
/mission-therapeutics-raises-%C2%A360-million-progress-devel... | MISSION Therapeutics raises £60 million to progress development of novel DUB inhibitors from innovative drug platform |
/mrc-technology-cancer-research-uk-and-cancer-research-techn... | MRC Technology, Cancer Research UK and Cancer Research Technology collaborate to focus on cancer immunotherapies |
/merck-ventures-creates-new-immuno-oncology-company-ionctura | Merck Ventures Creates New Immuno-Oncology Company iOnctura |
/metastasis | Metastasis Workshop 2015 |
/ncri-cancer-conference-2014 | NCRI Cancer Conference 2014 |
/ncri-cancer-conference-2015 | NCRI Cancer Conference 2015 |
/ncri-cancer-conference-2016 | NCRI Cancer Conference 2016 |
/nemucore-medical-innovations-options-clinical-stage-aurora-... | Nemucore Medical Innovations Options Clinical-Stage Aurora Kinase Inhibitor GSK1070916 From CRT |
/networking-top-luncheon | Networking at the Top Luncheon |
/catapult | New collaboration for CAR-T cell immuno-oncology therapy development |
/new-offices-crt-inc | New offices for CRT Inc. |
/helix-2014 | ON Helix 2014 |
/pdx-models-workshop-2014 | PDX Models Workshop 2014 |
/pdx-workshop | PDX Workshop |
/preclinical-models-network-taking-shape | Preclinical models network taking shape |
/crt-pioneer-fund-licenses-oncology-drug-targeting-dna-damag... | ProNAi Licenses Oncology Drug Targeting DNA Damage Response Checkpoint Kinase 1 (Chk1) from CRT Pioneer Fund |
/promising-results-phase-1-trial-lead-immatics-continue-work... | Promising results in Phase 1 trial lead immatics to continue work on vaccine (IMA950) for glioblastoma |
/rd-alliance-restructure-presents-new-dna-damage-response-pa... | R&D alliance restructure presents new DNA damage response partnership opportunities including leading PolQ project |
/Sachs | Sachs 15th Annual Biotech in Europe Forum |
/scancell-and-cancer-research-uk-collaborate-advance-novel-c... | Scancell and Cancer Research UK collaborate to advance novel cancer immunotherapy into clinical trials |
/stemline-therapeutics-obtains-worldwide-rights-novel-select... | Stemline Therapeutics obtains worldwide rights to novel selective RET inhibitor |
/storm-therapeutics-secures-%C2%A312m-investment-cancer-ther... | Storm Therapeutics secures £12m investment for cancer therapeutics |
/success-all-round-cancer-research-uk-supported-spinouts-obn... | Success all round for CRUK supported spinouts at the OBN annual awards |
/successful-completion-phase-i-trial-gsk1070916 | Successful completion of the Phase I trial of GSK1070916 |
/takeda-and-gammadelta-therapeutics-announce-collaboration-a... | Takeda and GammaDelta Therapeutics Announce Collaboration to Advance Tissue-derived gamma delta (γδ) T Cells |
/crt-pioneer-fund-and-cancer-research-uk%E2%80%99s-mancheste... | The CRT Pioneer Fund and Cancer Research UK’s Manchester Institute nominate cancer drug candidate |
/cancer-research-uk-innovation-summit | The Cancer Research UK Innovation Summit |
/three-new-companies-join-cancer-research-uk-abcodia-collabo... | Three new companies join Cancer Research UK-Abcodia collaboration to identify blood markers for early cancer detection |
/tumour-analysis-following-surgery-could-provide-breakthroug... | Tumour analysis following surgery could provide breakthrough in predicting how well cancer patients respond to drug treatment |
/two-cancer-research-technology-deals-shortlisted-leading-in... | Two Cancer Research Technology deals shortlisted for leading industry awards |
/ucl%E2%80%99s-cancer-immunology-group-publishes-relevance-c... | UCL’s Cancer Immunology group publishes on the relevance of CD25 as a target in cancer |
/valneva-and-blink-therapeutics-confirm-launch-and-funding-b... | Valneva and BliNK Therapeutics confirm launch and funding of BliNK Biomedical |
/world-pharma-licensing-congress-2014 | World Pharma Licensing Congress 2014 |
/%C2%A350m-crt-pioneer-fund-announces-investment-develop-lun... | £50M CRT Pioneer Fund announces invest to develop lung cancer drugs at Cancer Research UK's Manchester Institute |
/carrick-therapeutics-licenses-targeted-ovarian-cancer-treat... | Carrick Therapeutics in-licenses targeted ovarian cancer treatment discovered at the ICR |
/careers | Careers |
/vacancies | Current Vacancies |
/contact-us | Contact Us |
/node?qt-front_page_tabs=0#qt-front_page_tabs | LATEST NEWS |
/node?qt-front_page_tabs=1#qt-front_page_tabs | EVENTS |
/node?qt-front_page_tabs=2#qt-front_page_tabs | |
news-and-events?qt-news_tabs=3#qt-news_tabs | View upcoming events |
/our-company | About |
/licensing-opportunites | Licensing Opportunities |
/terms-conditions | Terms & Conditions |
cancertechnology.co.uk/modern-slavery-statement | Modern Slavery Statement |
/legal-status | Legal Status |
/cookie-policy | Click here |
Domain name:
cancertechnology.co.uk
Data validation:
Nominet was able to match the registrant's name and address against a 3rd party data source on 03-Oct-2018
Registrar:
Easyspace Ltd [Tag = EASYSPACE]
URL: https://www.easyspace.com/domain-names/extensions/uk
Relevant dates:
Registered on: 09-Sep-2002
Expiry date: 09-Sep-2023
Last updated: 20-Sep-2016
Registration status:
Registered until expiry date.
Name servers:
ns1.namecity.com
ns2.namecity.com
WHOIS lookup made at 22:35:58 03-Dec-2018
--
США - Станфорд - 171.66.121.222
Stanford University
Stanford University
HTTP/1.1 200 OK
Server: nginx
Date: Mon, 30 Dec 2019 11:37:32 GMT
Cache-Control: public, max-age=3600
Content-Type: text/html; charset=utf-8
X-Drupal-Cache: MISS
X-Content-Type-Options: nosniff
Content-Language: en
X-Frame-Options: SAMEORIGIN
Last-Modified: Mon, 30 Dec 2019 10:36:32 GMT
Expires: Sun, 19 Nov 1978 05:00:00 GMT
Vary: Cookie,Accept-Encoding
X-Request-ID: v-3f1d0826-2af0-11ea-baf0-22000a55af8f
X-AH-Environment: prod
Age: 405
ETag: W/"1577702192-1"
Via: varnish
X-Cache: HIT
X-Cache-Hits: 7
Accept-Ranges: bytes
Content-Length: 122744
Connection: keep-alive
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"